Publicaciones en colaboración con investigadores/as de Universidad de Zaragoza (4)

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

2014

  1. Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 1, Núm. 4